Abstract
The role of osmolality of contrast media (CM) in the development of post-ERCP pancreatitis (PEP) is debated. We therefore performed a metanalysis to determine whether osmolality affects the incidence of PEP. A literature search of English-language studies was performed using computerized databases and manual searching of abstracts and article bibliographies. Randomized controlled trials comparing the incidence of PEP associated with high- and low-osmolality contrast media (HOCM, LOCM) were considered. The outcome assessed was clinical pancreatitis as evidenced by both elevation of pancreatic enzymes and pain. Data were analyzed using logistic regression with terms for study and osmolality. Fisher's exact test was done to compare PEP rates. Homogeneity between studies was indicated by the nonsignificance of the study effect in the logistic regression model. Logistic regression also indicated no difference in PEP rates between LOCM and HOCM (P=0.399). Comparison of PEP rates in both groups using Fisher's exact test did not indicate a difference in any individual study (all P values >0.05). Due to the large variation of study sample sizes, we repeated the analysis by creating three study groups. The effect of osmolality was invariant to how the data were combined. The results of this metanalysis indicate that there is no significant difference between HOCM and LOCM with respect to clinical PEP.
Similar content being viewed by others
References
Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Shaw MJ, Snady HW, Erickson RV, Moore JP, Roel JP: Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 54(4):425-434, 2001
Sherman S, Lehman GA: ERCP and endoscopic sphincterotomy induced pancreatitis. Pancreas 6:350-367, 1991
Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM: Complications of endoscopic biliary sphincterotomy. N Engl J Med 335:909-918, 1996
Haber G: Prevention of post-ERCP pancreatitis. Gastrointest Endosc 51(1):1-7, 2000
Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ: Complications of endoscopic sphicterotomy: a prospective series with emphasis on increased risk associated with non dilated bile ducts and sphicter of Oddi dysfunction. Am J Gastroenterol 89:327-333, 1994
Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1-10, 1998
Bub H, Burner W, Riemann JF, Stolte M: Morphology of the pancreatic ductal epithelial after traumatization of the papilla of Vater or endoscopic retrograde pancreaticography with various contrast media in cats. Scand J Gastroenterol 18:581-592, 1983
Saari A, Kivisaari L, Standertskjold-Nordenstam CG, Brackett K, Schroder T: Experimental pancreatography: A comparison of three contrast media. Scand J Gastroenterol 23(1):53-58, 1988
Kimmey M, Al-Kawas F, Carr-Locke D, Edmundowicz SA, Gannan RA, Jamidar PA, Saeed ZA, Stein TN: Technology assessment status evaluation. Radiographic contrast media used in ERCP. Gastrointest Endosc 43:647-651, 1996
Osnes M, Skjennald A, Larsen S: A comparison of a new non-ionic (metrizamide) and a dissociable (metroizoate) contrast medium in endoscopic retrograde pancreaticography (ERP). Scand J Gastroenterol 12:821-825, 1977
Cunliffe WJ, Cobden I, Lavelle MI, Lendrum R, Tait NP, Venables CW: A randomized prospective study comparing two contrast media in ERCP. Endoscopy (Suppl) 19:201-202, 1987
O'Connor HJ, Ellis WR, Manning AP, Lintott DJ, McMahon MJ, Axon AT: Iopamidol as contrast medium in endoscopic retrograde pancreatography: A prospective randomized comparison with diatrizoate. Endoscopy 20(5):244-247, 1988
Banerjee A, Grainger S, Thompson R: Trial of low versus high osmolar contrast media in endoscopic retrograde cholangio-pancreatography. BJCP 44(11):445-446, 1990
Barkin JS, Casal GL, Reiner DK, Goldberg RI, Phillips RS, Kaplan S: A comparative study of contrast agents for endoscopic retrograde pancreatography. Am J Gastroentrol 86(10):1437-1441, 1991
Rodriguez J, Stoltenberg P, Avots A, Nipper M.L, Riggs M, Lasater J, Dyck WP: A prospective randomized comparison of the safety and efficacy of iohexol 180 and diatrizoate 60% as contrast agents for ERCP [abstract]. Gastroenterology 100:297, 1991
Hamilton I, Lintott DJ, Rothwell J, Axon AT: Metrizamide as contrast medium in endoscopic retrograde cholangio-pancreaticography. Clin Radiol 33(3):293-295, 1982
Hannigan BF, Keeling PW, Slavin B, Thompson RP: Hyperamylasemia after ERCP with ionic and non-ionic contrast media. Gastrointest Endosc 31(2):109-110, 1985
Jensen AR, Malchow-Moller A, Matzen P, Larsen JE, Moller F, Andersen JR, Magid E: A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography. Scand J Gastroenterol 1:83-86, 1985
Makela P, Dean PB: The frequency of hyperamylasemia after ERCP with diatrizoate and iohexol. Eur J Radiol 6(4):303-304, 1986
Silverman W, Ruffolo T, Rogers D, Hawes R: Post ERCP pancreatitis (PEP); frequency with ionic and non-ionic contrast media in high risk patients [abstract]. Am J Gastroenterol 86:192, 1991
Sherman S, Hawes RH, Rathgaber SW, Uzer MF, Smith MT, Khusro QE, Silverman WB, Earle DT, Lehman GA: Post-ERCP pancreatitis: randomized, prospective study comparing a low-and high osmolality contrast agent. Gastrointest Endosc 40(4):422-427, 1994
Johnson GK, Geenen JE, Bedford RA, Johanson J, Cass O, Sherman S, Hogan WJ, Ryan M, Silverman W, Edmundowicz S: A comparision of nonionic versus ionic contrast media: results of a prospective multicenter study. Gastrointest Endosc 42(4):312-316, 1995
Kruse A, Brock A, Rodenberg J, Nowakowska-Duawa E, Bjartveit K: Iopenol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde changio-pancreatography (ERCP): A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase and diagnostic information (VAS). Eur Radiol 7 (Suppl 4):S131-S134, 1997
Johnson GK, Geenen JE, Johanson JF, Sherman S, Hogan WJ, Cass O: Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Gastrointest Endosc 46(3):217-222, 1997
Martin DF, England RE, Rosch T, Biehl E, Jeschke B, Heldwein D, Klauser A, Klaveness A, Kristoffersen D: Diagnostic quality in endoscopic retrograde cholangiopancreatography: Comparison between iodixanol and iopromide. Endoscopy 32(10):783-787, 2000
Goebel C, Hardt P, Doppl W, Temme H, Hackstein N, Klor HU: Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial. Eur Radiol 10:677-680, 2000
Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N: Endoscopic sphincterotomy, complications and their management. An attempt at consensus. Gastrointest Endosc 37:383-393, 1991
Cotton PB: Outcomes of endoscopy procedures: struggling towards definitions. Gastrointest Endosc 40(4):514-518, 1994
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
Cotton PB, Brazer SR: Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography [letter]. Am J Gastroenterol 87(5):682, 1992
Ioannou G, Doust J, Rockey DC: Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev (1):CD002147, 2001
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
George, S., Kulkarni, A.A., Stevens, G. et al. Role of Osmolality of Contrast Media in the Development of Post-ERCP Pancreatitis: A Metanalysis. Dig Dis Sci 49, 503–508 (2004). https://doi.org/10.1023/B:DDAS.0000020511.98230.20
Issue Date:
DOI: https://doi.org/10.1023/B:DDAS.0000020511.98230.20